HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ku-Geng Huo Selected Research

Ku-Geng Huo Research Topics

Disease

5Hypertension (High Blood Pressure)
01/2022 - 05/2017
5Vascular System Injuries
01/2022 - 05/2017
2Lung Neoplasms (Lung Cancer)
01/2022 - 10/2020
2Neoplasms (Cancer)
01/2022 - 01/2020
2Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 01/2019
1Pulmonary Tuberculosis
04/2024
1Vascular Remodeling
01/2022
1Adenocarcinoma of Lung
01/2022
1Chronic Renal Insufficiency
01/2022
1Atherosclerosis
01/2019

Drug/Important Bio-Agent (IBA)

4Angiotensin IIIBA
01/2019 - 05/2017
3MicroRNAs (MicroRNA)IBA
01/2022 - 01/2019
2Phosphotransferases (Kinase)IBA
01/2022 - 01/2020
2Messenger RNA (mRNA)IBA
01/2022 - 01/2019
2AngiotensinsIBA
12/2017 - 05/2017
1Rifampin (Rifampicin)FDA LinkGeneric
04/2024
1dabrafenibIBA
01/2022
1VemurafenibIBA
01/2022
1Tyrosine Kinase InhibitorsIBA
01/2022
1trametinibIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2020
1Transcription Factors (Transcription Factor)IBA
01/2019
1Matrix Metalloproteinases (MMPs)IBA
12/2017
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
12/2017
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
05/2017

Therapy/Procedure

1Therapeutics
10/2020